2014 Q4 Form 10-Q Financial Statement

#000121390014007791 Filed on November 06, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $1.735M $1.126M $1.076M
YoY Change 71.95% 4.65% -35.91%
Cost Of Revenue $469.0K $422.0K $765.0K
YoY Change 135.68% -44.84% 127.0%
Gross Profit $1.266M $704.0K $311.0K
YoY Change 56.3% 126.37% -76.83%
Gross Profit Margin 72.97% 62.52% 28.9%
Selling, General & Admin $2.330M $2.182M $1.378M
YoY Change 22.63% 58.35% -31.31%
% of Gross Profit 184.04% 309.94% 443.09%
Research & Development $2.080M $1.767M $2.211M
YoY Change 6.67% -20.08% 52.38%
% of Gross Profit 164.3% 250.99% 710.93%
Depreciation & Amortization $50.00K $70.00K $40.00K
YoY Change 25.0% 75.0% 33.33%
% of Gross Profit 3.95% 9.94% 12.86%
Operating Expenses $4.410M $3.949M $3.589M
YoY Change 14.84% 10.03% 3.82%
Operating Profit -$3.144M -$3.245M -$3.278M
YoY Change 3.76% -1.01% 54.99%
Interest Expense $80.00K $30.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$30.00K
YoY Change
Pretax Income -$3.100M -$3.245M -$3.278M
YoY Change 2.31% -1.01% 54.99%
Income Tax $10.00K $65.00K
% Of Pretax Income
Net Earnings -$3.107M -$3.245M -$3.343M
YoY Change 1.97% -2.93% 55.92%
Net Earnings / Revenue -179.08% -288.19% -310.69%
Basic Earnings Per Share
Diluted Earnings Per Share -$767.9K -$802.5K -$943.5K
COMMON SHARES
Basic Shares Outstanding 40.46M shares 40.46M shares 35.44M shares
Diluted Shares Outstanding 40.46M shares 35.44M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.130M $8.840M $10.57M
YoY Change -30.5% -16.37% -6.04%
Cash & Equivalents $6.129M $8.844M
Short-Term Investments
Other Short-Term Assets $215.0K $1.150M $1.300M
YoY Change 7.5% -11.54% 242.11%
Inventory
Prepaid Expenses
Receivables $1.106M $558.0K $1.085M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.948M $10.56M $12.95M
YoY Change -28.63% -18.48% -1.56%
LONG-TERM ASSETS
Property, Plant & Equipment $654.0K $758.0K $365.0K
YoY Change 95.22% 107.67% 7.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.00K
YoY Change
Total Long-Term Assets $654.0K $758.0K $434.0K
YoY Change 95.22% 74.65% 27.65%
TOTAL ASSETS
Total Short-Term Assets $7.948M $10.56M $12.95M
Total Long-Term Assets $654.0K $758.0K $434.0K
Total Assets $8.602M $11.31M $13.38M
YoY Change -25.01% -15.46% -0.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $566.0K $651.0K $426.0K
YoY Change 18.16% 52.82% -14.46%
Accrued Expenses $935.0K $848.0K $896.0K
YoY Change -4.4% -5.36% 21.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $60.00K $70.00K
YoY Change
Total Short-Term Liabilities $4.965M $4.817M $4.801M
YoY Change -3.08% 0.33% 25.39%
LONG-TERM LIABILITIES
Long-Term Debt $370.0K $410.0K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $370.0K $410.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.965M $4.817M $4.801M
Total Long-Term Liabilities $370.0K $410.0K $0.00
Total Liabilities $5.332M $5.227M $4.801M
YoY Change 4.08% 8.87% 25.39%
SHAREHOLDERS EQUITY
Retained Earnings -$165.9M -$162.8M -$148.6M
YoY Change 9.38% 9.54% 8.91%
Common Stock $40.00K $40.00K $38.00K
YoY Change 5.26% 5.26% 15.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.270M $6.087M $8.582M
YoY Change
Total Liabilities & Shareholders Equity $8.602M $11.31M $13.38M
YoY Change -25.01% -15.46% -0.82%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$3.107M -$3.245M -$3.343M
YoY Change 1.97% -2.93% 55.92%
Depreciation, Depletion And Amortization $50.00K $70.00K $40.00K
YoY Change 25.0% 75.0% 33.33%
Cash From Operating Activities -$2.770M -$3.040M -$2.420M
YoY Change 22.03% 25.62% 952.17%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$10.00K -$110.0K
YoY Change 0.0% -90.91% 450.0%
Acquisitions
YoY Change
Other Investing Activities $10.00K
YoY Change
Cash From Investing Activities -$10.00K -$10.00K -$110.0K
YoY Change -50.0% -90.91% 450.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.900M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K -20.00K 7.750M
YoY Change -101.82% -100.26% 5066.67%
NET CHANGE
Cash From Operating Activities -2.770M -3.040M -2.420M
Cash From Investing Activities -10.00K -10.00K -110.0K
Cash From Financing Activities -10.00K -20.00K 7.750M
Net Change In Cash -2.790M -3.070M 5.220M
YoY Change 60.34% -158.81% -5320.0%
FREE CASH FLOW
Cash From Operating Activities -$2.770M -$3.040M -$2.420M
Capital Expenditures -$20.00K -$10.00K -$110.0K
Free Cash Flow -$2.750M -$3.030M -$2.310M
YoY Change 22.22% 31.17% 1000.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Neonode, Inc
dei Entity Central Index Key
EntityCentralIndexKey
0000087050
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40455352 shares
CY2012Q4 us-gaap Cash
Cash
9097000 usd
CY2013Q3 us-gaap Cash
Cash
10568000 usd
CY2013Q4 us-gaap Cash
Cash
8815000 usd
CY2014Q3 us-gaap Cash
Cash
8844000 usd
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
969000 usd
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
558000 usd
CY2013Q4 us-gaap Investments In Power And Distribution Projects
InvestmentsInPowerAndDistributionProjects
736000 usd
CY2014Q3 us-gaap Investments In Power And Distribution Projects
InvestmentsInPowerAndDistributionProjects
503000 usd
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
616000 usd
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
651000 usd
CY2013Q4 us-gaap Assets Current
AssetsCurrent
11136000 usd
CY2014Q3 us-gaap Assets Current
AssetsCurrent
10556000 usd
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
335000 usd
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
758000 usd
CY2013Q4 us-gaap Assets
Assets
11471000 usd
CY2014Q3 us-gaap Assets
Assets
11314000 usd
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
479000 usd
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
651000 usd
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
978000 usd
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
848000 usd
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3666000 usd
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3252000 usd
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
usd
CY2014Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
66000 usd
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5123000 usd
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4817000 usd
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
usd
CY2014Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
410000 usd
CY2013Q4 us-gaap Liabilities
Liabilities
5123000 usd
CY2014Q3 us-gaap Liabilities
Liabilities
5227000 usd
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
38000 usd
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
40000 usd
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
157994000 usd
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
168875000 usd
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
11000 usd
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-6000 usd
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151695000 usd
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-162822000 usd
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6348000 usd
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
6087000 usd
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11471000 usd
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11314000 usd
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37933799 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40455352 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37933799 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40455352 shares
CY2013Q3 us-gaap Revenues
Revenues
1076000 usd
us-gaap Revenues
Revenues
2708000 usd
CY2014Q3 us-gaap Revenues
Revenues
1126000 usd
us-gaap Revenues
Revenues
3005000 usd
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
765000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1443000 usd
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
422000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1040000 usd
CY2013Q3 us-gaap Gross Profit
GrossProfit
311000 usd
us-gaap Gross Profit
GrossProfit
1265000 usd
CY2014Q3 us-gaap Gross Profit
GrossProfit
704000 usd
us-gaap Gross Profit
GrossProfit
1965000 usd
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2211000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5286000 usd
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1767000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5293000 usd
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
406000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2104000 usd
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
725000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2523000 usd
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
972000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3813000 usd
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1457000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5275000 usd
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3589000 usd
us-gaap Operating Expenses
OperatingExpenses
11203000 usd
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
3949000 usd
us-gaap Operating Expenses
OperatingExpenses
13091000 usd
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3278000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9938000 usd
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3245000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11126000 usd
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
95000 usd
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3343000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10033000 usd
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3245000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11127000 usd
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35437000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34366000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40455000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39219000 shares
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-46000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8000 usd
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-82000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17000 usd
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3389000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10025000 usd
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3327000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11144000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2101000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1594000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
18000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1040000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-393000 usd
neond Projects In Process
ProjectsInProcess
usd
neond Projects In Process
ProjectsInProcess
-229000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-458000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-176000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-32000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
252000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
748000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-381000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6529000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9053000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6899000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9253000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
524000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
699000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
36000 usd
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
usd
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
18000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8122000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9271000 usd
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
14000 usd
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-91000 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1471000 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
29000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000 usd
us-gaap Interest Paid
InterestPaid
95000 usd
us-gaap Interest Paid
InterestPaid
8000 usd
neond Supplemental Non Cash Purchase Of Equipment With Capital Lease Obligation
SupplementalNonCashPurchaseOfEquipmentWithCapitalLeaseObligation
usd
neond Supplemental Non Cash Purchase Of Equipment With Capital Lease Obligation
SupplementalNonCashPurchaseOfEquipmentWithCapitalLeaseObligation
530000 usd
neond Non Cash Investing And Finacing Excersice Warrent Price
NonCashInvestingAndFinacingExcersiceWarrentPrice
3000 usd
neond Non Cash Investing And Finacing Excersice Warrent Price
NonCashInvestingAndFinacingExcersiceWarrentPrice
usd
neond Non Cash Investing And Finacing Stock Subscription Receivable
NonCashInvestingAndFinacingStockSubscriptionReceivable
286000 usd
neond Non Cash Investing And Finacing Stock Subscription Receivable
NonCashInvestingAndFinacingStockSubscriptionReceivable
usd
neond Revenue Percentage Net
RevenuePercentageNet
1.00 pure
us-gaap Use Of Estimates
UseOfEstimates
<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Estimates</i></b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">The preparation of financial statements in conformity with U.S. GAAP requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectibility of accounts receivable, recoverability of capitalized project costs and long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.</font></p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Concentration of Credit and Business Risks</i></b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our customers are located in the Americas, Europe and Asia.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of December 31, 2013, two customers represented approximately 56% of the Company&#8217;s consolidated accounts receivable.&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of September 30, 2014, two customers represented approximately 77% of the Company&#8217;s consolidated accounts receivable.&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During the three and nine months ended September 30, 2014, one and four customers represented approximately 30% and 49% of our consolidated net revenues, respectively.</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">During the three and nine months ended September 30, 2013, three and four customers represented approximately 64% of our consolidated net revenues, respectively.</font></p></div>
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Deferred Revenue</i></b></font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.25in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">&#160;</font></p><p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">From time-to-time we receive pre-payments from our customers related to future services or future license fee revenues.&#160;We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed or licensed by our customers and the engineering development fee revenue until such time as the engineering work has been completed and accepted by our customers.</font></p></div>
CY2014Q3 neond Excess Of Insurance Limits
ExcessOfInsuranceLimits
8400000 usd
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18000 usd
CY2013Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
-33000 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
157000 usd
CY2014Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
86000 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
120000 usd
CY2013Q3 us-gaap Advertising Expense
AdvertisingExpense
31000 usd
us-gaap Advertising Expense
AdvertisingExpense
160000 usd
CY2014Q3 us-gaap Advertising Expense
AdvertisingExpense
18000 usd
us-gaap Advertising Expense
AdvertisingExpense
147000 usd
CY2013Q3 neond Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss
WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLoss
6.55 pure
neond Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss
WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLoss
6.51 pure
CY2014Q3 neond Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss
WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLoss
6.94 pure
neond Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss
WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLoss
6.67 pure
CY2013Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
6.48 pure
CY2014Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.26 pure
neond Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss One
WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLossOne
96.63 pure
neond Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss One
WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLossOne
102.94 pure
CY2013Q4 neond Foreign Currency Exchange Rate Translation One
ForeignCurrencyExchangeRateTranslationOne
105.22 pure
CY2014Q3 neond Foreign Currency Exchange Rate Translation One
ForeignCurrencyExchangeRateTranslationOne
109.43 pure
CY2014Q3 neond Conversion Of Warrant Into Common Stock Shares Converted
ConversionOfWarrantIntoCommonStockSharesConverted
10053 shares
CY2014Q3 neond Value Of Warrants
ValueOfWarrants
36000 usd
CY2014Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.13
CY2014Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
17000 shares
CY2014Q3 neond Class Of Warrant Or Right Additional Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightAdditionalNumberOfSecuritiesCalledByWarrantsOrRights
11500 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2500000 shares
CY2014Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.00
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
762000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2101000 usd
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1594000 usd
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
965000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2014Q3 neond Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Warrants Outstanding And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsOutstandingAndExercisableNumber
3335073 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y10M24D
neond Number Of Equity Incentive Plan
NumberOfEquityIncentivePlan
2 plans
neond Number Of Non Employee Director Stock Option Plan
NumberOfNonEmployeeDirectorStockOptionPlan
1 plans
neond Placement Agent Fee
PlacementAgentFee
600000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Next Rolling Twelve Months
CapitalLeasesFutureMinimumPaymentsNextRollingTwelveMonths
26000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Two
CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo
85000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Three
CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree
85000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Four
CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour
85000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Five
CapitalLeasesFutureMinimumPaymentsDueInRollingYearFive
85000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due In Rolling After Year Five
CapitalLeasesFutureMinimumPaymentsDueInRollingAfterYearFive
172000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
538000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
62000 usd
CY2014Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
476000 usd
CY2010Q1 neond Nonrecurring Development Cost
NonrecurringDevelopmentCost
500000 usd
CY2012Q4 neond Nonrecurring Development Cost
NonrecurringDevelopmentCost
500000 usd
CY2010Q1 neond Description Of Development Cost Contributed
DescriptionOfDevelopmentCostContributed
Under the terms of the NN1001 Agreement, we will reimburse TI an NRE fee of $0.08 per unit for each of the first one million units sold and $0.05 for the next eight million units sold.
CY2012Q4 neond Description Of Development Cost Contributed
DescriptionOfDevelopmentCostContributed
Under the terms of the NN1002 Agreement we will reimburse TI an NRE fee of $0.25 per unit for each of the first two million units sold.
CY2010Q1 neond Nonrecurring Development Cost One
NonrecurringDevelopmentCostOne
0.08
CY2010Q1 neond Nonrecurring Development Cost Two
NonrecurringDevelopmentCostTwo
0.05
CY2012Q4 neond Non Recurring Development Cost Three
NonRecurringDevelopmentCostThree
0.25
CY2013Q3 neond Nonrecurring Expense Related To Agreement
NonrecurringExpenseRelatedToAgreement
93000 usd
neond Nonrecurring Expense Related To Agreement
NonrecurringExpenseRelatedToAgreement
344000 usd
CY2014Q3 neond Nonrecurring Expense Related To Agreement
NonrecurringExpenseRelatedToAgreement
14000 usd
neond Nonrecurring Expense Related To Agreement
NonrecurringExpenseRelatedToAgreement
74000 usd
neond Payment Made Under Agreement
PaymentMadeUnderAgreement
387000 usd
CY2014Q3 neond Accounts Payable Under Agreement
AccountsPayableUnderAgreement
93000 usd
CY2014Q2 neond Capital Lease Term Of Contract
CapitalLeaseTermOfContract
P6Y
CY2014Q2 us-gaap Description Of Lessee Leasing Arrangements Capital Leases
DescriptionOfLesseeLeasingArrangementsCapitalLeases
Under the terms of the lease agreement we are obligated to purchase the equipment at the end of the original 6 year lease term for 10% of the original purchase price of the equipment.
CY2014Q2 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
21000 usd
CY2014Q2 us-gaap Capital Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
CapitalLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.04 pure
CY2013Q3 neond Revenue Percentage Net
RevenuePercentageNet
1.00 pure
CY2014Q3 neond Revenue Percentage Net
RevenuePercentageNet
1.00 pure
neond Revenue Percentage Net
RevenuePercentageNet
1.00 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segments
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35437000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34366000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40455000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39219000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35437000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34366000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40455000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39219000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
9300000 usd

Files In Submission

Name View Source Status
0001213900-14-007791-index-headers.html Edgar Link pending
0001213900-14-007791-index.html Edgar Link pending
0001213900-14-007791.txt Edgar Link pending
0001213900-14-007791-xbrl.zip Edgar Link pending
f10q0914ex31ii_neonode.htm Edgar Link pending
f10q0914ex31i_neonode.htm Edgar Link pending
f10q0914ex32i_neonode.htm Edgar Link pending
f10q0914_neonode.htm Edgar Link pending
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
neond-20140930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
neond-20140930_cal.xml Edgar Link unprocessable
neond-20140930_def.xml Edgar Link unprocessable
neond-20140930_lab.xml Edgar Link unprocessable
neond-20140930_pre.xml Edgar Link unprocessable
neond-20140930.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable